Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer

BACKGROUND: Immune checkpoint blockade therapy with anti‐programmed cell death (PD)‐1 antibodies provides therapeutic effect for many patients of various cancers but remains inadequate in colorectal cancer (CRC) patients. The present study aims to assess the efficacy of oncolytic adenovirus (Onco(Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lili, Zhao, Huaxin, Shan, Mengying, Chen, Hong, Xu, Bin, He, Yang, Zhao, Yu, Liu, Zhuqing, Chen, Jianhua, Xu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741988/
https://www.ncbi.nlm.nih.gov/pubmed/35762456
http://dx.doi.org/10.1002/cam4.4845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741988/
https://www.ncbi.nlm.nih.gov/pubmed/35762456
http://dx.doi.org/10.1002/cam4.4845

Ejemplares similares